Pharvaris BV (PHVS) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $28.00
• Market Cap: $1.79B
• EPS: $-3.42
• 52-Week High: $29.80
• 52-Week Low: $11.51

Market Sentiment

Pharvaris BV currently has a Bullish sentiment score of 0.52.

About Pharvaris BV

Pharvaris BV is a clinical-stage biopharmaceutical company headquartered in Leiden, the Netherlands, focused on developing innovative therapies for rare diseases, particularly hereditary angioedema. With a strong commitment to addressing significant unmet medical needs, the company utilizes its proprietary drug development platform to advance its therapeutic pipeline. Pharvaris aims to enhance the quality of life for patients affected by this orphan disease, positioning itself as a key player...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Pharvaris BV and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PHVS pay dividends?

Pharvaris BV (PHVS) does not currently pay a regular dividend.

What is PHVS's market cap?

Pharvaris BV (PHVS) has a market capitalization of $1.79B with a current stock price of $28.00.